IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
79 hedge funds and large institutions have $208M invested in IGM Biosciences in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 74 → 79 (+5)
15% less capital invested
Capital invested by funds: $245M → $208M (-$37.8M)
Holders
79
Holding in Top 10
–
Calls
$226K
Puts
$166K
Top Buyers
| 1 | +$11.9M | |
| 2 | +$10.2M | |
| 3 | +$8.65M | |
| 4 |
Millennium Management
New York
|
+$8.56M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.62M |
Top Sellers
| 1 | -$9.78M | |
| 2 | -$3.35M | |
| 3 | -$3.03M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.78M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.37M |